Akebia Ther
Drug Manufacturers - Specialty & Generic
Healthcare
AKBA
210 M shares
NASDAQ US
traded
14 Apr 2025
listed
no
open
1.71
52 week high
2.84
high
1.86
52 week low
0.86
low
1.66
growth
72.64 %
previous Close
1.65
P/E ratio
market cap
404 M
div yield
0
usd
Sep 2024
qoq
revenue
37.43 M
-14.25 %
net incoming
-20.04 M
-133.50 %
eps
0.00 %
-150.00 %
eps surprise
-66.67 %
net profit margin
-53.54 %
-33.00 %
operating incoming
-12.51 M
-43.32 %
net change in cash
-3.81 M
-54.59 %
cash on hand
34.02 M
-13.87 %
cost of revenue
14.16 M
-18.83 %
top top